This on-demand webinar, presented by GP Dr Peter Eizenberg, Professor Lucy Morgan and Pharmacist Debbie Rigby, will help GPs and other primary healthcare providers to better understand the epidemiology of RSV in older adults with comorbidities in Australia and the importance of preventive measures, including RSV vaccination and includes the latest updates in the Australian Immunisation Handbook chapter on RSV.
On completion of this education activity participants will be able to:
- Outline how the clinical burden of respiratory syncytial virus (RSV) in older adults has been historically underestimated.
- Explain the evidence of serious outcomes with RSV infection in older adults, especially those with comorbidities.
- Describe the current recommendations on RSV and influenza vaccine co-administration in older adults.
- Educate appropriate patients about RSV vaccines in Australia, and outline their efficacy and potential side effects.
This on-demand webinar is part of a series on RSV, other activities include:
On-demand webinar: RSV in older adults: understanding risk and preventative measures
Presented by GP Dr Peter Eizenberg, Professor Lucy Morgan, and Pharmacist Debbie Rigby
Dr Peter Eizenberg
Dr Peter Eizenberg is a GP consulting at, and the former Director of, ‘Doctors of Ivanhoe’. Whilst maintaining his GP commitments, Dr Eizenberg is also a Principal Investigator with various vaccine research trials for vaccines including Influenza, RSV & Zoster. Dr Eizenberg has held a number of national immunisation committee & advisory group positions, including current membership on the NCIRS AusVaxSafety Advisory Group & the Immunisation Coalition SAC. He is also the past Chair of North East Valley Division of General Practice.
Professor Lucy Morgan
Professor Lucy Morgan is an adult respiratory and sleep physician. Lucy is a proud graduate of the University of Newcastle, trained at Concord Hospital and completed a PhD in chronic lung disease at the University of Sydney. Her clinical practice covers a wide range of lung problems including airways diseases (asthma and COPD, bronchiectasis), pulmonary fibrosis, lung infections and lung cancer. Lucy is committed to a multidisciplinary approach to respiratory health care and has strong links to other clinicians.
Lucy has academic appointments at Macquarie University and Sydney University with a strong interest in teaching and training junior doctors and lung researchers throughout the Macquarie University Hospital, Nepean Hospital and Concord Hospital Clinical Schools. Lucy has a very active clinical research portfolio. She is chair of the Australasian Bronchiectasis Consortium and the clinical lead for the Australian Bronchiectasis Registry project. She is currently the president of the NSW TSANZ , is a Director of Lung Foundation Australia, a member of the Australian Lung Cancer Trials Group and Director of Research for the Nepean Lung Cancer Group. She is widely published and an invited speaker at National and International conferences.
Debbie Rigby
Debbie Rigby is an Advanced Practice Pharmacist with postgraduate qualifications in clinical pharmacy, geriatrics and respiratory medicine. Debbie is the Clinical Executive Lead at National Asthma Council Australia. She is a member of Pharmaceutical Society of Australia Respiratory Community of Special Interest and Respiratory Pharmacy Taskforce, Lung Foundation Australia COPD Advisory Committee and Primary Care Committee, and the International Primary Care Respiratory Group. The Lung Foundation Australia honoured Debbie as the 2023 Lung Health Legend. Debbie conducts Home Medicine Reviews and provides medicines education to pharmacists, nurses, GPs and other health professionals through her company Pharmeducation.
This on-demand webinar has been approved as a Lung Learning Quality-Assured Activity. It can be viewed at https://www.lunglearninghub.com.au
This on-demand webinar is part of a series on RSV, other activities include:
On-demand webinar: RSV in older adults: understanding risk and preventative measures
This session is sponsored by GSK.
